We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
A phase II study of YM155, a novel small-molecule suppressor of survivin, in castration-resistant taxane-pretreated prostate cancer.
- Authors
Tolcher, A W; Quinn, D I; Ferrari, A; Ahmann, F; Giaccone, G; Drake, T; Keating, A; de Bono, J S
- Abstract
YM155, a small-molecule survivin suppressor, showed modest single-agent activity in a phase I study of heavily pretreated patients. This study was conducted to determine the activity of YM155 in patients with castration-resistant prostate cancer (CRPC) who received prior taxane therapy.
- Publication
Annals of oncology : official journal of the European Society for Medical Oncology, 2012, Vol 23, Issue 4, p968
- ISSN
1569-8041
- Publication type
Journal Article
- DOI
10.1093/annonc/mdr353